Davidson Matt 4
4 · Verrica Pharmaceuticals Inc. · Filed Aug 9, 2019
Insider Transaction Report
Form 4
Davidson Matt
10% Owner
Transactions
- Sale
Common Stock
2019-08-08$10.76/sh−3,118$33,550→ 2,580,954 total - Sale
Common Stock
2019-08-09$10.21/sh−2,773$28,312→ 2,578,181 total - Sale
Common Stock
2019-08-07$10.28/sh−422$4,338→ 2,584,072 total
Footnotes (4)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 22, 2018.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.07 to $10.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.48 to $11.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.